Private Sector and the Healthcare Industry in Africa

In most African countries, the private sector plays a significant role in the healthcare industry, contributing more than 60%. This contribution has been especially crucial during the Covid-19 pandemic, where the private sector’s role in early diagnostics has been remarkable, especially in Nigeria.
The leading causes of mortality among children in this region are vaccine-preventable diseases. It’s puzzling why “chemist stores” or “pharmacies” can’t provide vaccinations when they can be supported to do so.
Also, many malaria cases are treated without a confirmatory test at chemist stores, where RDTs are not readily available. However, studies have shown that low-level community health workers can use malaria RDT correctly.
Antibiotic resistance is another major concern in Africa, with many solutions directed at addressing the issue only in hospital-based settings. But this is not the complete reality. Does the chemist store in Oshodi in Lagos or Kasuwa Magani in Kaduna understand what antibiotic stewardship is? The root cause of the problem stems from a lack of recognition and integration of these groups into the health system.
The peculiar problems facing African healthcare systems require tailored solutions beyond replicating the NHS or the US healthcare models.
The private sector is crucial in achieving Universal Health Coverage by 2030. This will, however, require a concerted effort from healthcare professionals and policymakers. By addressing the healthcare system’s peculiar challenges, Africa can develop a healthcare model that caters to its unique needs while still offering quality healthcare to its citizens.